Pulmonary Pharmacology and Therapeutics
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.8 | Q2 | 74.8% | 0.819 | Q2 | 78.0% |
| 2024 | 2.8 | Q2 | 60.2% | 0.790 | Q2 | 77.5% |
| 2023 | 3.3 | Q2 | 69.9% | 0.786 | Q2 | 79.2% |
| 2022 | 3.2 | Q3 | 63.4% | 0.776 | Q2 | 79.7% |
| 2021 | 3.3 | Q3 | 62.2% | 0.671 | Q2 | 76.2% |
| 2020 | — | — | 1.061 | Q1 | 86.6% | |
| 2019 | — | — | 0.851 | Q2 | 81.9% | |
| 2018 | — | — | 0.952 | Q1 | 83.0% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1522-9629
ISSN
1094-5539
region
Northern America
coverage
1997-2026